Neuralink advances and brain chip starts to develop real skills

Neuralink, a company founded by Elon Musk, has achieved extraordinary progress in the area of neurotechnology.

In the first successfully implanted patient, the brain chip began to demonstrate its real capabilities, allowing the individual to carry out simple commands through telepathy.

Elon Musk recently announced that the human patient was able to control the cursor of a computer mouse with just his thoughts, developing an important skill for research.

The notable progress marks a significant milestone in the development of Neuralink technology, with the company already planning its next steps.

Neuralink announces first brain chip – Image: Reproduction

The next goal is to further expand the patient’s abilities, aiming to get as many mouse button clicks as possible with just thought, paving the way for even more impressive possibilities in the future.

The first steps of brain chip implantation

At the end of January, Neuralink performed the first brain implant in a human being, called ‘Telepathy’.

This item is inserted by a robot in a specific region of the brain, responsible for controlling the intention of movement.

The purpose of the device is to help people who suffer from paralysis, such as quadriplegia, by allowing them to control electronics, such as computers and cell phones, with just their thoughts.

This has been one of Musk’s biggest investments, who is also CEO of Tesla, X (formerly Twitter) and other companies.

Neuralink also intends to evaluate the safety of both the implant and the robot used in the surgical procedure, in addition to monitoring the progress of the patient’s capabilities.

The goal is to examine three main aspects: the implant itself, the R1 robot and the N1 User App, a software that connects to the Neuralink implant and translates brain signals into computational actions.

For reasons of confidentiality, the Neuralink chose not to provide additional information about the progress of the experiment, including the condition of the patient who received the first brain implant.